IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
70
Employees70
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
70
Employees70

IGC Key Statistics

Market cap
38.28M
Market cap38.28M
Price-Earnings ratio
-5.06
Price-Earnings ratio-5.06
Dividend yield
Dividend yield
Average volume
840.32K
Average volume840.32K
High today
$0.4349
High today$0.4349
Low today
$0.38
Low today$0.38
Open price
$0.4091
Open price$0.4091
Volume
595.05K
Volume595.05K
52 Week high
$0.4985
52 Week high$0.4985
52 Week low
$0.2525
52 Week low$0.2525

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.